Skip to content

Clinical trials

Phase 2 Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 2 Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20072
20084
20093
20104
20112
20121
20132
20162
20177
20182
20192
20202
20214
20225
20237
20242
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Active, not recruiting8
Terminated7
Withdrawn4
Recruiting4
Unknown status2
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis4
Alkahest, Inc.3
Inmune Bio, Inc.3
Novartis Pharmaceuticals3
Alterity Therapeutics2
Flex Pharma, Inc.2
MapLight Therapeutics2
Merck Sharp & Dohme LLC2
National Institute of Neurological Disorders and Stroke (NINDS)2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases62
Central Nervous System Diseases29
Alzheimer Disease28
Nervous System Diseases27
Brain Diseases23
Dementia20
Mental Disorders14
Parkinson Disease14
Neurocognitive Disorders13
Cognitive Dysfunction12

Trials

Showing 76 to 62 of 62. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.